Take a test for herpes simplex virus type 1,2 (herpes simplex virus, hsv), igg antibodies in Kyiv, Med-Help clinic
Med-Help Clinic in Kyiv offers analysis for the herpes simplex virus type 1,2 (Herpes Simplex Virus, HSV) by determining IgG antibodies. This type of analysis can help to find out whether a person is infected with the herpes simplex virus and whether he is immune to it.
Herpes simplex virus type 1,2 is a well-known disease transmitted by contact. It causes blisters on the skin and mucous membranes. Primary infection can occur with symptoms of fever, headache and muscle pain. Once transmitted, the virus can remain in the body for life and cause relapses of the disease.
The analysis for the herpes simplex virus type 1,2 in the Med-Help clinic is carried out using high-precision equipment. The results of the analysis are ready within a few days. They will help the doctor determine the presence of the virus in the patient’s body and measures to prevent its transmission to other people.
The analysis for the herpes simplex virus type 1,2 can be prescribed both to confirm the diagnosis and to check for immunity to the virus. This analysis does not require any special preparation on the part of the patient, it is enough to give blood from a vein.
Med-Help Clinic employs highly qualified specialists who will help you properly prepare for the test and answer all your questions. After receiving the test results, the doctor will consult you and explain its meaning. If the result is positive, he will help you choose the best treatment and give recommendations for disease prevention.
Med-Help Clinic provides its patients with a convenient online appointment booking service, which allows you to save time on visiting the clinic and avoid queues. In addition, our clinic provides a wide range of medical services and prompt assistance in emergency cases.
If you suspect infection with the herpes simplex virus type 1,2, do not postpone the analysis for later. Contact the Med-Help clinic and receive qualified medical care.
